CD274 and neoplasm: Patients with advanced tumor stage (p = 0.003), T stage (p = 0.002), N stage (p = 0.002), negative PD-L1 expression (p = 0.048), and vascular invasion (p = 0.013), exhibited poorer DFS (Figures 2B–F).